- $39.87bn
- $49.71bn
- £11.03bn
Director Declaration
Newscasts - GSK chief Walmsley to be replaced early by insider Luke Miels
British drugmaker GSK tops FTSE 100 as Walmsley to step down as chief
Director/PDMR Shareholding
Holding(s) in Company
Director/PDMR Shareholding
Brief: Wellnex Life Limited Receives Order From Haleon For UAE Market
UK's Haleon falls on Barclays' downgrade, PT cut
Director/PDMR Shareholding
UK's Haleon rises after GS upgrade
Director/PDMR Shareholding
Holding(s) in Company
UK Stocks-Factors to watch on August 14 (updated)
Director/PDMR Shareholding
Holding(s) in Company
Director/PDMR Shareholding
Sensodyne-maker Haleon hits 1-year low on cutting sales growth forecast
Brief: Haleon Expects FY Organic Revenue Growth To Be Around 3.5%
UK Stocks-Factors to watch on July 31 (updated)